Please contact us via email: email@example.com
If you are unable to see the message below, click here to view
In order to control the global outbreak of COVID-19 efficiently, it is necessary to develop assays, which can allow rapid qualitative analysis of the viral antibody. CUSABIO has released the ELISA kits for the detection of SARS-CoV-2 N IgG antibody.
This assay employs the qualitative enzyme immunoassay technique with high sensitivity and high specificity. the samples used in the assay is serum or plasma, which is securer than others with the feature of low toxicity or no virus. And the operation is convenient and the cost is low, which can realize fast and large-scale batch operation.